Article PDF
Avoid common mistakes on your manuscript.
References
Garrod AE. Inborn Factors in Disease: an Assay. Oxford University Press; 1931.
Haidane JBS. Disease and evolution. La Ricerca Scientifica 1949; 19: 68–75.
Fosdick LS, Hansen HL. A study of the products of metabolism of procain hydrochloride. Dental Cosmos 1931; 73: 1082–4.
Brodie BB, Lief PA, Poet R. The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethy-laminoethanol. J Pharmacol Exp Ther 1948; 94: 359–66.
Herken H. Untersuchungen an serumproteinen bei eiweissmangelernahrung. Arztl Wochenschr 1949; 4: 297–302.
Herken H, Kalow W. Photometometrische bestimmung der enzymatischen novocain-hydrolyse. Klin Wochenschr 1951; 29: 90–1.
Aviado DM Jr, Li TH, Kalow W, et al. Respiratory and circulatory reflexes from the perfused heart and pulmonary circulation of the dog. Am J Physiol 1951; 165: 261–77.
Mendel B, Rudney H. Studies on cholinesterase. I. Cholinesterase and pseudocholinesterase. Biochem J 1943; 37: 59–63.
Kalow W. Hydrolysis of local anesthetics by human serum cholinesterase. J Pharmacol Exp Ther 1952; 104: 122–34.
Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955; 135: 568–74.
Bovet-Nitti F. Degradazione di alcune sostanze curarizzanti per azione di cholinesterasi. R C 1st sup Sanita 1949; 12: 138–57.
Kalow W, Genest K A. method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can J Biochem Physiol 1957; 35: 339–46.
Kalow W, Staron N. On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem Physiol 1957; 35: 1305–20.
Kalow W, Gunn DR. The relation between dose of succinylcholine and duration of apnea in man. J Pharmacol Exp Ther 1957; 120: 203–6.
Lehmann H, Ryan E. The familial incidence of low pseudocholinesterase level. Lancet 1956; 2: 126.
Kalow W. Familial incidence of low pseudo-cholinesterase level. Lancet 1956; 2: 576–7.
Jensen FS, Schwartz M, Viby-Mogensen J. Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand 1995, 39: 142–9.
Beutler E. The molecular biology of G6PD variants and other red cell enzyme defects. Annu Rev Med 1992; 43: 47–59.
Bonicke R, Reif W. Enzymatische inaktivierung von isonicotinsaure-hydrazid im menschlichen und tierischen Organismus. Arch Exper Pathol Pharmakol 1953; 220: 321.
Hughes HB, Biehl JP, Jones AP, Schmidt LH. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberculosis 1954; 70: 266–73.
Motulsky AG. Drug reactions, enzymes, and biochemical genetics. JAMA 1957; 165: 835–7.
Vogel F. Moderne probleme der humangenetik. Ergebnisse der inneren medizin und kinderheilkunde 1959; 12: 65–126.
Kalow W. Pharmacogenetics. Heredity and the Response to Drugs. Philadelphia, London: W.B. Saunders Company; 1962.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalow, W. Atypical plasma cholinesterase. A personal discovery story: a tale of three cities. Can J Anesth 51, 206–211 (2004). https://doi.org/10.1007/BF03019096
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03019096